Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on understanding the best treatment approaches of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Todd Bauer as the primary speaker and Dr. Ullas Batra as a moderator who will share the important facts associated with treatment approaches for management of ALK positive lung cancer.
Dr. Todd Bauer has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, a discussion on all possible treatment approaches and their pros, cons are discussed.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
finding fresh approaches to treating diffuse midline gliomas.
2.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
3.
According to JAMA, statin use may increase cancer-related survival in breast cancer patients.
4.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
5.
Getting More Done With Less Blood.
1.
Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients
2.
Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer
3.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
4.
Genetic Screening: A Game Changer in Cancer Prevention
5.
Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Navigating the Complexities of Ph Negative ALL - Part X
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation